Current protocols in protein science / editorial board, John E. Coligan ... [et al.] 2001-05-01

Modification of cysteine.

M W Crankshaw, G A Grant

Index: Curr. Protoc. Protein Sci. Chapter 15 , Unit15.1, (2001)

Full Text: HTML

Abstract

This unit describes a number of methods for modifying cysteine residues of proteins and peptides by reduction and alkylation procedures. A general procedure for alkylation of cysteine residues in a protein of known size and composition with haloacyl reagents or N-ethylmaleimide (NEM) is presented, and alternate protocols describe similar procedures for use when the size and composition are not known and when only very small amounts of protein are available. Alkylations that introduce amino groups using bromopropylamine and N-(iodoethyl)-trifluoroacetamide are also presented. Two procedures that are often used for subsequent sequence analysis of the protein, alkylation with 4-vinylpyridine and acrylamide, are described, and a specialized procedure for 4-vinylpyridine alkylation of protein that has been adsorbed onto a sequencing membrane is also presented. Reversible modification of cysteine residues by way of sulfitolysis is described, and a protocol for oxidation with performic acid for amino acid compositional analysis is also provided. Gentle oxidation of cysteine residues to disulfides by exposure to air is detailed. Support protocols are included for recrystallization of iodoacetic acid, colorimetric detection of free sulfhydryls, and desalting of modified samples.


Related Compounds

  • 3-Bromopropylamine...

Related Articles:

Direct Pore Binding as a Mechanism for Isoflurane Inhibition of the Pentameric Ligand-gated Ion Channel ELIC.

2015-01-01

[Sci. Rep. 5 , 13833, (2015)]

Inhibition of tissue-bound semicarbazide-sensitive amine oxidase by two haloamines, 2-bromoethylamine and 3-bromopropylamine.

2001-01-01

[Arch. Biochem. Biophys. 385(1) , 154-61, (2001)]

Rational design of ligands targeting triplet repeating transcripts that cause RNA dominant disease: application to myotonic muscular dystrophy type 1 and spinocerebellar ataxia type 3.

2009-07-22

[J. Am. Chem. Soc. 131(28) , 9767-79, (2009)]

Inhibition of copper amine oxidase by haloamines: a killer product mechanism.

1997-03-04

[Biochemistry 36(9) , 2595-602, (1997)]

Identification of cysteine residues alkylated with 3-bromopropylamine by protein sequence analysis.

1993-04-01

[Anal. Biochem. 210(1) , 39-44, (1993)]

More Articles...